Randy Keim
Senior Director of HCP & Consumer Marketing | Sanofi
Randy Keimsecurehost2025-11-11T19:52:05+00:00
November 2025
In this DHCG Disruptive Dose, Mark Bard of the DHC Group speaks with Randy Keim, Senior Director of HCP & Consumer Marketing at Sanofi, about implementing AI-powered personalization in pharmaceutical marketing. Keim shares how successful AI adoption requires organizational transformation and change management, not just new technology, emphasizing that AI should enhance rather than replace human judgment in healthcare marketing. The conversation explores how marketers can move beyond basic segmentation toward individualized experiences at scale while maintaining authenticity and compliance. Keim discusses measuring meaningful ROI through KPIs that connect AI-driven personalization to tangible outcomes, and offers candid insights on separating genuine AI transformation from hype, noting that real value comes from strategically applying AI to solve specific challenges that help healthcare professionals and patients receive relevant, timely information.